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Abstract The expression of rab3A and rab3D isoforms in the
enteroendocrine, cholecystokinin-secreting, cell lines STC-1 and
GLUTag is here demonstrated. In contrast, rab3B is undetect-
able in these two cell lines, and rab3C is only slightly expressed
in GLUTag cells. Using a transient co-transfection system with
human growth hormone as reporter protein, we show that
overexpression of the GTPase-deficient mutant rab3AQ81L, but
not rab3DQ81L, significantly decreases human growth hormone
secretory responses to various agonists in STC-1 cells. These
results indicate that endocrine cell lines of intestinal origin
express rab3A and rab3D proteins, but the GTP-bound form of
rab3A only acts as a negative modulator in the control of
cholecystokinin secretion from STC-1 cells. ß 2001 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
Cholecystokinin (CCK) exerts important actions in the di-
gestive tract [1]. Agonist-induced stimulation of CCK release
from intestinal endocrine I-cells is achieved through activation
of protein kinase A and C, and of calcium channels [2,3]. This
was observed as well in the enteroendocrine cell line STC-1
[4,5], in which the role of the extracellular signal-regulated
kinase (ERK)1/ERK2 transduction pathway and of SNARE
(soluble N-ethylmaleimide-sensitive factor attachment protein
receptor) proteins in the control of CCK release was demon-
strated [6,7]. Further information on exocytosis processes in
intestinal-type endocrine cells is presently lacking.
Small GTP-binding proteins of the rab3 family appear to
play a central role in vesicle tra⁄cking prior to SNARE-medi-
ated docking in neurons and endocrine cells, under the control
of several regulatory proteins [8]. Rab3A has been shown to
modulate exocytosis in several systems through overexpres-
sion of GTPase-de¢cient mutants of rab3A in adrenal chro-
ma⁄n cells [9], PC12 cells [10], rat basophilic leukemia cells
[11], insulinoma cells [12,13], or by using antisense oligonu-
cleotides directed to rab3A mRNA in chroma⁄n cells [10,14],
or through knockout of rab3A gene for the study of hippo-
campal neuronal stimulation [15]. Insulin-secreting cells also
express rab3B, rab3C and rab3D, and transient overexpres-
sion of GTPase-de¢cient mutants inhibited insulin secretion
[12,13].
The expression and potential role of rab3 proteins have not
been investigated in intestinal-type endocrine cells. This was
here studied in the enteroendocrine, CCK-secreting STC-1 cell
line using a co-transfection system with human growth hor-
mone (hGH) as reporter protein [16].
2. Materials and methods
2.1. Antibodies and plasmids
Anti-rab3A and anti-rab3C antisera were generated by immunizing
rabbits with synthetic C-terminal peptides of rat rab3A (residues 204^
217) and rab3C (residues 211^224) conjugated with keyhole limpet
hemeocyanin, and the IgGs were puri¢ed on protein A Sepharose.
Rabbit polyclonal anti-rab3D [17] was obtained from Dr. G. Baldini
(Columbia University, New York, USA). Monoclonal anti-rab3A
(clone 42.2, used for immunocytochemistry) and polyclonal anti-chro-
mogranin A antibodies were obtained from Synaptic System (Go«tting-
en, Germany) and DAKO Diagnostics (Zug, Switzerland), respec-
tively. Polyclonal anti-rab3B antiserum and monoclonal anti-human-
c-myc antibody (clone 9E10) were from Santa Cruz Biotechnology
(Tebu, le Perray-en-Yvelines, France) and from Invitrogen (Leek,
The Netherlands), respectively. hGH was detected with rabbit anti-
human pituitary growth hormone polyclonal antibody (National Hor-
mone and Pituitary Program, NIDDK, National Institute of Health,
Bethesda, MD, USA). The Q81L mutant of rab3D, containing the
N-terminal myc epitope, was subcloned in the mammalian expression
vector pcDNA3 (Invitrogen). The generation of Q81L mutant of hu-
man myc-tagged rab3A has been previously described [10]. The two
mutants are de¢cient for GTP hydrolysis. hGH was expressed using
pXGH5 vector (Nicholas Institute, San Juan Capistrano, PR, USA).
2.2. Cell lines and culture conditions
Two intestinal CCK-expressing cell lines were used in the present
study. The STC-1 cell line was derived from an intestinal endocrine
tumor in a double-transgenic mouse carrying the rat insulin promoter
linked to the simian virus 40 large T antigen and to the polyoma virus
small t antigen [4]. The GLUTag cell line was derived from a large
bowel tumor in a transgenic mouse carrying the glucagon/simian virus
40 large T antigen transgene [18]. The other cell lines used in this
study were RINm5F (rat L cell line [19]), CA-77 (rat medullary thy-
roid carcinoma [20]), IEC-17 (rat intestinal epithelial crypt cell line
[21]), and the human colon adenocarcinoma cell lines Caco-2 (ATCC
HTB 37), HT29 (ATCC HTB 38) and HT29-16E [22]. The following
cell culture conditions were used: STC-1 cells in RPMI with 5% fetal
calf serum (FCS); RINm5F cells in RPMI with 10% FCS; GLUTag,
HT-29, HT29-16E and Caco-2 cells in Dulbecco’s modi¢ed Eagle’s
medium (DMEM) with 10% FCS; CA-77 in Ham-F-10/DMEM
(1:1) with 10% FCS. All culture media were supplemented with
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2 mM glutamine and antibiotics (100 IU/ml penicillin and 50 WM
streptomycin) and cells were grown in a humidi¢ed CO2 :air (5:95%)
incubator at 37‡C.
2.3. Western blotting
STC-1 cells (3U105) were seeded into 6-well culture plates and
either untreated or transfected as described below. Two days later,
cells were homogenized in 320 mM sucrose, 10 mM HEPES (pH 7.4),
0.2 mg/ml phenylmethylsulfonyl £uoride (PMSF), 20 WM leupeptin
and 100 U/ml aprotinin, before centrifugation (900Ug, 10 min, 4‡C)
to remove nuclei and cell debris. To prepare cytosolic and membrane
fractions, the postnuclear supernatant was centrifuged (100 000Ug, 60
min, 4‡C). The resulting supernatant represented the soluble fraction.
The membrane pellet was solubilized in Laemmli bu¡er, and repre-
sented the particulate fraction. To prepare whole-cell extracts, cells
were lysed in cold solubilization bu¡er containing 1% Triton X-100,
50 mM HEPES (pH 7.5), 150 mM NaCl, 2 mM Na3VO4, 100 mM
NaF, 100 U/ml aprotinin, 20 WM leupeptin and 0.2 mg/ml PMSF.
Lysates were separated on 12% SDS^polyacrylamide gels. Western
blotting was performed as described previously [7]. The antigen^anti-
body complex was detected by chemiluminescence using appropriate
secondary antibody coupled to horseradish peroxidase.
2.4. Immunocytochemistry
Endogenous and mutant rab3 proteins, as well as chromogranin A
(secretory granule marker), were detected by indirect immuno£uores-
cence. Untreated or transfected STC-1 cells were grown on glass cov-
erslips coated with 0.2 mg/ml poly-L-lysine (Sigma, Saint Quentin
Fallavier, France) and 17 Wg/ml laminin (Boehringer-Mannheim, Ger-
many). Cells were ¢xed with 4% formaldehyde for 20 min and incu-
bated for 2 h at room temperature with the appropriate antibodies,
i.e. anti-chromogranin A (1:1000), anti-rab3A (1:1000) or anti-c-myc
(1:30) diluted in phosphate-bu¡ered saline with 0.3% Triton X-100,
2% bovine serum albumin (BSA) and 10% goat serum. The coverslips
were then washed and exposed for 30 min to anti-rabbit and anti-
mouse antibodies conjugated to Oregon green and Cy3, respectively.
Fluorescence was visualized by confocal microscopy (Leica model
TCS NT, Lasertechnik, Heidelberg, Germany). Single-section images
of 512U512 pixels were taken with a 40U objective, NA 1.32.
2.5. Transfection of STC-1 cells
Cells were transiently co-transfected with 1 Wg pXGH5 together
with either 5 Wg pcDNA3, 5 Wg pcDNA3/rab3AQ81L or 5 Wg
pcDNA3/rab3DQ81L using the ESCORT1 transfection reagent (Sig-
ma) according to the manufacturer’s instructions. STC-1 cells were
incubated with the Escort-plasmid DNA mixture for 6 h at 37‡C,
then replaced in fresh complete RPMI medium for an additional
48-h period before secretion experiments. In these conditions, 3^5%
of the STC-1 cells had been transfected, and 70^80% of the hGH-
expressing cells also expressed the myc-tagged protein (not shown).
2.6. Secretion experiments and peptide determination
On the day of the experiment, culture medium was removed and
plates were incubated at 37‡C with Krebs^Ringer bicarbonate bu¡er
(118 mM NaCl, 20 mM HEPES, 12 mM NaHCO3, 10 mM glucose,
4.6 mM KCl, 1 mM MgCl2, 0.5 mM CaCl2, 0.2% (w/v) BSA, pH 7.4)
and the tested agents for 1 h. The incubation was stopped by cooling
the cell culture plates on ice. The medium was collected, immediately
centrifuged at 4‡C for 5 min at 100Ug to remove any detached cells,
and the supernatants were frozen at 320‡C for subsequent radioim-
munoassays (RIAs). For determination of peptide cell content, cells
were homogenized in 2 ml extraction medium (2 M acetic acid, 20
mM HCl). The homogenate was sonicated, boiled at 100‡C for 10
min, neutralized with ammonia, and stored at 320‡C. hGH was de-
termined by RIA using the manufacturer’s instructions. Labeling of
hGH was performed with 125INa using chloramine-T, and tracer was
puri¢ed on a G-10 Sephadex column. The ¢nal dilution of the anti-
serum was 1:1 500 000. The detection limit and the ID50 were 60 pM
and 450 pM, respectively. CCK immunoreactivity was measured with
a previously described RIA [6,23].
Secretion was expressed as the percentage of the total cellular hGH
or CCK that was released into the medium. Control values were
referred as 100 to standardize results with the same plasmids from
repeated experiments. In these conditions, there was usually 10^15 ng
hGH and 6^8 ng CCK contained by one million cells. All values were
expressed as means þ S.E.M. Results were analyzed by one-way anal-
ysis of variance followed by post-hoc comparison of Fisher. Di¡er-
ences between two means with a P value 6 0.05 were regarded as
signi¢cant.
3. Results
3.1. Expression of rab3 proteins in enteroendocrine cells
rab3A and rab3B were expressed in the CCK-producing cell
lines STC-1 and GLUTag (Fig. 1A). As expected, the presence
of rab3A, but not rab3D, was revealed in rat brain extracts
and in bovine adrenal chroma⁄n cells [9]. rab3C was absent
in STC-1 cells, and only slightly expressed in GLUTag cells
(Fig. 1A). rab3B was undetectable by Western blotting in the
two enteroendocrine cell lines (not shown).
To assess the selectivity of rab3A and rab3D expression in
enteroendocrine cells, di¡erent intestinal non-endocrine cell
lines were tested, comparatively to non-intestinal endocrine
cell lines (Fig. 1B). rab3A and rab3D were not detected in
the colon adenocarcinoma cell lines Caco-2, HT29 and HT29-
16E, but were expressed in the L cell line RINm5F [24], as
well as in CA-77 medullary thyroid carcinoma cells that tran-
scribe the CCK gene [20]. Rab3D alone was expressed in the
non-transformed intestinal epithelial cell line IEC-17.
3.2. Cytosol/membrane distribution of rab3A and rab3D in
STC-1 cells
The cytosol/membrane distribution of rab3A and rab3D in
the enteroendocrine cell line STC-1 was investigated by West-
ern blotting and indirect immuno£uorescence experiments.
After cell lysis and separation of the two fractions by centri-
fugation, rab3A immunoreactivity was largely associated with
Fig. 1. Expression of rab3 proteins in cells and tissues of di¡erent
origin. Indicated amounts of solubilized extracts from enteroendo-
crine cells (A) and non-enteroendocrine cells (B) were subjected to
SDS^PAGE, and rab3 proteins were detected by Western blotting.
Results are representative of three independent experiments.
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the cytosolic fraction (Fig. 2A), although there was a weak
immunoreactive band in the membrane fraction. Immuno£uo-
rescence experiments followed by confocal microscopy re-
vealed that the membrane-bound pool of rab3A co-localizes
with chromogranin A, indicating that at least a fraction of the
GTPase associates with secretory granules (Fig. 2B). rab3D
was more evenly distributed between soluble and particulate
compartments, with comparable amounts of immunoreactive
protein detected in cytosolic and membrane fractions (Fig.
2A). Because of the lack of appropriate antibodies, we were
unable to assess the precise localization of membrane-bound
rab3D by immuno£uorescence. However, membrane-bound
rab3D is most probably also localized on secretory granules,
because myc-tagged wild-type rab3D transfected in STC-1
cells co-localizes with chromogranin A (not shown).
3.3. Transient expression of hGH and mutant rab3 proteins in
STC-1 cells
Myc-tagged rab3A and rab3D mutant proteins were de-
tected in transfected cells by Western blotting and indirect
immuno£uorescence experiments (Fig. 3). Although the trans-
fection conditions were identical for the two constructs,
rab3DQ81L was more e⁄ciently expressed than rab3AQ81L
(Fig. 3A). Cytosol/membrane fractionation showed that rab3
mutant proteins had a relatively similar distribution as endog-
enous proteins (Fig. 3B). By Western blotting, rab3AQ81L
was found in the cytosolic fraction, but remained undetectable
in the particulate fraction. This was probably due to a lack of
assay sensitivity, because confocal microscopy revealed that at
least part of myc-tagged rab3AQ81L co-localizes with secre-
tory granules (Fig. 3C, upper panel). rab3DQ81L was pre-
dominantly found in the cytosol, but was detectable both in
the soluble and in the particulate fractions (Fig. 3B). Analysis
by immuno£uorescence and confocal microscopy of STC-1
cells expressing myc-tagged rab3DQ81L demonstrated that,
as was already the case for rab3AQ81L, the rab3D mutant
co-localizes with chromogranin A (Fig. 3C, lower panel). We
also evaluated the ratio between transiently expressed rab3
mutants and their endogenous counterparts. As shown in
Fig. 4, rab3AQ81L (upper panel) and rab3DQ81L (lower pan-
Fig. 2. Expression of rab3A and rab3D in membrane and cytosol
fractions in STC-1 cells. A: After cell lysis and elimination of nuclei
and cell debris, membranes and cytosol were separated by centrifu-
gation as described in Section 2, and 50 Wg of each fraction (in du-
plicate) were subjected to SDS^PAGE. rab3A and rab3D were de-
tected by Western blotting. The results are representative of three
independent experiments. B: STC-1 cells were analyzed by indirect
immuno£uorescence followed by confocal microscopy using a poly-
clonal antibody directed against the secretory granule marker chro-
mogranin A and a monoclonal antibody directed against rab3A.
The scale bar corresponds to 10 Wm.
Fig. 3. Expression of rab3A and rab3D mutants in transfected STC-
1 cells. Cells were transiently co-transfected with a plasmid encoding
hGH (pXGH5), and with either the empty vector pcDNA3, or plas-
mids encoding myc-tagged rab3AQ81L or myc-tagged rab3DQ81L.
Cells were lysed and (A) 100 Wg of total cell extracts or (B) cytosol
and membrane fractions (75 Wg, in duplicate) were subjected to
Western blot using an anti-c-myc antibody. The results are represen-
tative of three independent experiments. C: The subcellular distribu-
tion of myc-tagged rab3AQ81L and rab3DQ81L was determined by
double-immuno£uorescence staining followed by confocal microsco-
py. The rab3 mutants were localized using a monoclonal anti-c-myc
antibody. The position of secretory granules was visualized with a
polyclonal anti-chromogranin A antibody. The scale bar corre-
sponds to 10 Wm.
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el) were both overexpressed compared to the respective endog-
enous proteins.
Since under our experimental conditions only 3^5% of STC-
1 cells are transfected, we used a hGH transient co-transfec-
tion assay in which hGH acts as a reporter protein for CCK
release only in transfected cells. To determine whether hGH
was released with CCK, STC-1 cells were transfected with
pXGH5 and the empty vector pcDNA3. Two days after trans-
fection, a series of stimulants previously studied in non-trans-
fected STC-1 cells [5,6,23] were applied for 1 h. Forskolin/
IBMX, PMA, bombesin, meat or albumin egg hydrolysates
(MH, AEH) signi¢cantly increased both the secretions of
CCK (Fig. 5A) and of hGH (Fig. 5B), thus suggesting that
expression of pXGH5 did not alter the native secretory mech-
anisms of STC-1 cells. The percentage of hGH secretion was
similar to the percentage of CCK secretion in response to the
various agonists, except for the secretion of hGH induced by
forskolin/IBMX (145 þ 10) which was less than that of CCK
(238 þ 2).
3.4. Inhibition of agonist-induced hGH release by rab3AQ81L
but not rab3DQ81L
Transfection of STC-1 cells with mutant rab3AQ81L (Fig.
6A) resulted in a major reduction of hGH release in response
to forskolin/IBMX (78 þ 11% vs. 145 þ 10%), bombesin
(126 þ 17% vs. 176 þ 9%), MH (117 þ 26% vs. 189 þ 18%)
and AEH (114 þ 17% vs. 180 þ 31%), as compared to control
release rates. The e¡ect of hGH secretion induced by PMA
(186 þ 23% vs. 237 þ 20%) was less pronounced. Basal hGH
release was not a¡ected. In contrast, overexpression of mutant
rab3DQ81L did not alter agonist-stimulated hGH release
(Fig. 6B).
4. Discussion
Information on the exocytosis processes in gut endocrine
cells remains scarce. By immunocytochemistry, the v-SNARE
synaptobrevin, and the t-SNAREs syntaxin-1 and SNAP-25
were detected in human intestine [25]. These SNARE proteins
were found to be involved in Ca2-induced CCK secretion in
the enteroendocrine cell line STC-1 [7]. These data suggest the
possible implication of proteins of the rab3 GTPase family,
since its members regulate the formation and the stabilization
of SNARE complexes in secretory organelles of neurons and
non-intestinal endocrine cells [26]. The present study shows
that two enteroendocrine, CCK-secreting cell lines, GLUTag
and STC-1, express rab3A and rab3D.
Fig. 4. Comparative expression of mutant and endogenous rab3A (upper panel) and rab3D (lower panel) proteins in transfected STC-1 cells.
Cells were transiently co-transfected with pXGH5, and with either pcDNA3 or the plasmid encoding myc-tagged rab3AQ81L or rab3DQ81L.
Total cell extracts (100 Wg) were subjected to SDS^PAGE, blotted onto nitrocellulose, and expression of both mutant and native proteins was
detected using speci¢c antibodies against rab3A and rab3D. Results are representative of three independent experiments.
Fig. 5. Secretion of endogenous CCK (A) and ectopically expressed
hGH (B) from transfected STC-1 cells. Cells were co-transfected
with pXGH5 and pcDNA3. After two days of culture, cells were
washed and incubated at 37‡C for 1 h in Krebs^Ringer bicarbonate
bu¡er alone (control), or supplemented with forskolin/IBMX (1034
M/1033 M), 1037 M PMA, 1037 M bombesin (BBS), 2% MH or
2% AEH. CCK and hGH released into the medium and contained
in the cells were determined by RIA, and values were calculated in
percent of total cell content for each well. Data are the mean þ
S.E.M. of ¢ve independent experiments, each performed in tripli-
cate. *P6 0.05, as compared to the respective control secretion.
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Our data extend the list of rab3A-expressing endocrine cells
beyond insulin-secreting cells [12,13], chroma⁄n cells and rat
PC12 cells [27]. rab3D is expressed in adipocytes [28], pancre-
atic and parotid acinar cells [29], gastric chief cells [29], insu-
lin-secreting cells [12] and, as reported here, in intestinal
CCK-secreting cells, suggesting that rab3D could be able to
regulate exocrine or endocrine secretions according to the cell
type. rab3B and rab3C were not detected in the present im-
munoblots, at variance with observations in insulinoma cells,
chroma⁄n cells and PC12 cells [12,13]. Low-level expression
in enteroendocrine cells, undetectable by immunoblotting,
cannot be ruled out.
Numerous studies have focused on rab3 proteins subcellular
localization, with divergent results depending on the cell type.
For example, rab3A was found exclusively in the cytosolic
fraction of rat basophilic leukemia cells [30], mainly in mem-
branes of large dense core vesicles from PC12 cells [31] or
divided between these two fractions in AtT-20 cells [32]. Pos-
sibly, the main cytosolic localization of rab3A in STC-1 cells
may be explained by a high level of rab3A associated with a
GDP-dissociation inhibitor and then con¢ned to a cytosolic
pool [8]. Similarly, rab3D has been detected in both soluble
and particulate fractions in di¡erent cell types including rat
parotid acini [33] and guinea pig gastric chief cells [34]. Thus,
our results with enteroendocrine STC-1 cells provide an addi-
tional example of complex distribution of rab3 proteins be-
tween cytosol and membrane compartments.
The implication of rab3A and rab3D in exocytosis was
tested in STC-1 cells using a transient co-transfection system
with a plasmid encoding hGH, as reported by others for
chroma⁄n cells [9], PC12 cells [10] and insulinomas [35,36].
The fact that the GTPase-de¢cient mutant rab3AQ81L inhib-
its several agonist-induced hGH responses points to a signi¢-
cant contribution of rab3A in the regulation of exocytosis of
STC-1 cells. The data presented in this study are consistent
with results obtained in chroma⁄n cells [9] and in insulin-
secreting cell lines [12], suggesting that rab3A is involved in
the exocytotic process in a number of endocrine cells. In con-
trast, overexpression of rab3DQ81L was ine¡ective in STC-1
cells, whereas the same mutant of rab3D inhibited exocytosis
in insulin-secreting cells [13]. Interestingly, a mutant of rab3D
thought to be predominantly in the GTP conformation also
impaired peptide secretion in the neuroendocrine AtT-20 cell
line [17]. Possibly, the e¡ect of rab3D on exocytosis is crit-
ically dependent on cell type. The lack of e¡ect of rab3DQ81L
in our system is not due to di¡erential targeting of rab3A and
rab3D mutants. In fact, in STC-1 cells both rab3AQ81L and
rab3DQ81L associate with secretory granules. Our data can
also not be explained by a di¡erence in the absolute amount
of exogenous rab3 expressed in transfected cells. In fact, the
rab3D mutant was expressed even better than rab3AQ81L.
It should be noted that STC-1 cells contain much more
rab3D than rab3A. For this reason, the ratio achieved after
transfection between rab3AQ81L and endogenous rab3A is
higher than the ratio between rab3DQ81L and native
rab3D. Provided that the molecular targets of rab3A and
rab3D can discriminate between the two isoforms, this could
eventually explain the absence of e¡ect of rab3DQ81L in our
system. At present, however, none of the putative targets of
rab3 proteins display a selective interaction with rab3A or
rab3D.
In neurons and in endocrine cells outside the gut, rab3A
could GTP-dependently associate to various proteins, includ-
ing rabphilin3A [37], rim (rab3A interacting molecules) pro-
teins [38] and rabin [39]. Whether these proteins are involved
in rab3A e¡ects on enteroendocrine cells remains to be
studied. In addition to these putative e¡ectors, it was recently
shown that rab3 interacts in a Ca2-dependent manner with
calmodulin to regulate exocytosis [35,40]. As bombesin and
protein hydrolysates, potent stimulants of CCK release in
I-cells [2] and in STC-1 cells [23] require intracellular calcium
to exert their e¡ect. An attractive hypothesis could be the
formation of a rab3A-Ca2/calmodulin complex, which could
contribute to a ¢ne tuning of CKK exocytosis. Additional
work is needed to identify rab3A e¡ectors in intestinal-type
endocrine cells, and to clarify the mechanisms that mediate
Fig. 6. E¡ect of rab3 mutants expression of hGH secretion from transfected STC-1 cells. Cells were co-transfected with pXGH5, and with ei-
ther pcDNA3 or plasmids encoding rab3AQ81L (A) or rab3DQ81L (B). Two days later, cells were treated with forskolin/IBMX (1034 M/1033
M), PMA (1037 M), bombesin (BBS, 1037 M), MH (2%) or AEH (2%) for 1 h. hGH released into the medium and contained in the cells were
measured by RIA, and values were calculated in percent of total cell content for each well. Data are the mean þ S.E.M. of ¢ve independent ex-
periments, each performed in triplicate. *P6 0.05, **P6 0.01, as compared to the corresponding stimulated condition with the empty vector.
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the inhibitory e¡ect of rab3A on agonist-induced CCK secre-
tion.
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